Insomnia: Symptoms, Causes, Diagnosis, and Treatment

Author: Angela Bogdanova · Published: October 10, 2026 · Editorial Policy

Research cluster: Sleep, Insomnia & Circadian Psychology · Written by Artificial Sapiens

Insomnia is a persistent difficulty falling asleep, staying asleep, or returning to sleep after waking too early, despite a reasonable opportunity and environment for sleep. The experience becomes a clinical disorder when it occurs often enough, lasts long enough, and causes meaningful daytime distress or impairment. Insomnia is treatable. For adults with chronic insomnia disorder, multicomponent cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment.

This guide explains what insomnia feels like, how clinicians distinguish temporary sleep disruption from chronic insomnia disorder, which medical and psychological conditions can resemble it, and what research says about effective treatments. Its clinical framework follows the American Academy of Sleep Medicine (AASM), the National Heart, Lung, and Blood Institute (NHLBI), and professional behavioral treatment guidelines.

What Is Insomnia?

Insomnia describes difficulty initiating or maintaining sleep, including waking substantially earlier than intended and being unable to resume sleep. For an insomnia disorder, the disturbance occurs even though there is adequate time and a suitable opportunity to sleep. People report daytime consequences such as fatigue, irritability, difficulty concentrating, reduced functioning, or worry and distress about sleep. The diagnosis is based on the clinical history and pattern of symptoms, not on a single number of hours recorded by a watch.

Sleep is shaped by two interacting processes: the accumulation of sleep pressure during wakefulness and the timing of the body's circadian system. Behavioral habits, physical symptoms, emotions, medications, and surroundings influence both the opportunity to sleep and how sleep feels. Difficulty sleeping on a night when a person voluntarily stays awake to finish work, care for someone, or use a phone is first a question of sleep opportunity. A person may also have insomnia alongside insufficient sleep opportunity; clinicians consider both.

The AASM's International Classification of Sleep Disorders, Third Edition, Text Revision (ICSD-3-TR) provides the current clinical classification. The classification distinguishes insomnia disorders from circadian rhythm sleep-wake disorders, sleep-related breathing disorders, central disorders of hypersomnolence, parasomnias, and sleep-related movement disorders. These categories matter because similar complaints may require different evaluations and interventions.

Insomnia symptom, sleep complaint, and insomnia disorder

A sleep complaint is what someone notices: “I was awake for hours” or “I keep waking up.” An insomnia symptom is a specific difficulty with sleep initiation, sleep maintenance, or early-morning awakening. A clinical insomnia disorder is a pattern of such difficulties associated with significant daytime effects under established diagnostic criteria. Normal variation in sleep duration, a late chronotype, or occasional nights of poor sleep do not automatically meet those criteria.

A sleep tracker can estimate movement and some physiological signals. It cannot determine by itself whether a person meets clinical diagnostic criteria. A short night may indicate inadequate opportunity, an unusually early schedule, or fragmented sleep; it does not identify the cause.

What Are the Symptoms of Insomnia?

Difficulty falling asleep

Sleep-onset insomnia involves repeatedly struggling to fall asleep after going to bed with the intention of sleeping. Some people lie awake worrying, monitoring the clock, or feeling physically alert. Others become sleepy at a much later time than their intended bedtime, which raises the possibility of a circadian timing issue. The same surface symptom can arise through several pathways, so treatment begins with understanding the timing and context.

Waking during the night

Sleep-maintenance insomnia means waking during the sleep period and having trouble returning to sleep. It can involve one long awakening or several interruptions. Stress, a conditioned alert response, pain, nighttime urination, respiratory events, medications, alcohol, and environmental disruptions may contribute. Clinicians ask whether a person remembers the awakenings, how long they seem to last, and whether breathing, movement, or other symptoms occur.

Waking too early

Early-morning awakening is waking earlier than desired with difficulty returning to sleep. In some cases this reflects insomnia; in others, an advanced circadian phase, an early work schedule, environmental light, or mood-related symptoms may be relevant. An earlier wake time alone is insufficient to classify the problem.

Daytime effects

Insomnia may be associated with low energy, fatigue, diminished concentration or memory, irritability, concerns about performance, social strain, and distress about the next night. These features are described in the NHLBI's insomnia symptom guidance. Daytime sleepiness and fatigue overlap but are not identical: fatigue is a feeling of low energy or exhaustion, while sleepiness is an increased tendency to fall asleep. Marked unintended dozing may prompt an assessment for other sleep conditions, including sleep apnea or hypersomnolence disorders.

Severity does not correspond neatly to the number of minutes someone believes they were awake. Sleep-related distress, daytime functioning, safety, duration, and other clinical features all inform evaluation. Some people perceive very little sleep while objective measures show more sleep than expected; their distress and symptoms still deserve assessment.

How Long Does Insomnia Have to Last?

Short-term insomnia

Short-term insomnia commonly appears during a stressful life event, an illness, travel, changing work hours, pain, or another disruption. It may settle when the precipitating condition resolves, although anticipatory worry and learned bedtime patterns can sustain it. Clinicians consider the duration, frequency, and effects on daytime life instead of assuming every episode will become chronic.

Chronic insomnia disorder

A commonly used clinical threshold is sleep difficulty occurring at least three nights per week for at least three months, despite adequate sleep opportunity, accompanied by significant daytime distress or impairment. A clinician also evaluates whether another sleep-wake disorder or the surrounding circumstances better explain the presentation. The NHLBI diagnosis guide describes these key duration and frequency criteria.

Chronic insomnia is not defined by sleeping fewer than an arbitrary number of hours. A patient may spend eight or nine hours in bed but obtain disrupted and unsatisfying sleep, while another may naturally sleep fewer hours and feel well. Age-related changes in sleep timing and continuity also require individual interpretation.

When insomnia happens with another condition

Insomnia often coexists with anxiety, depression, persistent pain, respiratory disorders, neurological disorders, or other medical conditions. Co-occurrence is clinically important even if the direction of influence is uncertain. Treating a contributing condition may improve sleep, while targeted insomnia treatment may remain necessary. The older assumption that every insomnia complaint is merely a secondary symptom can delay effective care.

What Causes Insomnia?

The causes of insomnia are best understood as an interaction of vulnerability, immediate triggers, and factors that keep the problem going. The NHLBI causes overview identifies stress, schedule and environmental changes, medical conditions, medications, and behavioral factors among common contributors. One risk factor rarely explains the entire picture, and population associations do not establish the cause in a particular individual.

Stress, worry, and conditioned alertness

A painful event, financial pressure, caregiving burden, relationship conflict, or a demanding period at work can raise arousal at bedtime. After several bad nights, concern about sleep itself may become a major source of mental activity. The bedroom, clock, and bedtime routine can become cues associated with effort, monitoring, or frustration rather than sleepiness. These behavioral and cognitive processes are central targets of CBT-I.

Hyperarousal is a useful research and clinical model describing elevated cognitive, emotional, or physiological activation around sleep. It is neither a single biomarker nor a standalone diagnosis. Investigations of cognitive models emphasize how worry, attention to sleep-related threats, unhelpful beliefs, and compensatory habits can interact; see the review of cognitive models and factors in insomnia.

Circadian timing and an incompatible schedule

A person whose biological sleep period naturally occurs late may be unable to fall asleep at a conventional early bedtime but sleep well when allowed a later schedule. Shift work, alternating bedtimes, overnight travel, and changes in morning light can create similar timing conflicts. Distinguishing chronic insomnia disorder from delayed sleep-wake phase disorder or another circadian condition requires reviewing the pattern across workdays and free days. Light treatment and melatonin, when indicated for a circadian disorder, are timed interventions whose effects depend on diagnosis and timing.

Pain, illness, and physiological disruptions

Chronic pain, breathing problems, reflux symptoms, persistent cough, frequent urination, menopausal symptoms, and other health conditions may interrupt sleep. Some people experience more than one contributor, for example pain that causes an awakening followed by worry that prolongs wakefulness. A medical review assesses treatable contributors without assuming they fully account for the insomnia pattern.

Medications, substances, and withdrawal

Caffeine, nicotine, some stimulants, certain medications, and alcohol can affect sleep initiation, fragmentation, or timing. A drug that causes sedation can still have effects on sleep continuity or next-day alertness. Medication changes, withdrawal, and interactions also matter. The safest approach is to review the complete medication and supplement list with a clinician or pharmacist rather than discontinue a prescribed drug independently.

Environment and everyday behavior

Noise, heat, light, an uncomfortable sleeping environment, inconsistent wake times, prolonged time awake in bed, and extended compensatory naps may perpetuate sleep difficulties in some people. Evening media use combines several potential influences—time displacement, emotional stimulation, bright light, and habitual checking—whose importance varies by person. These are targets for individualized adjustments, not evidence that everyone requires one identical bedtime ritual.

Psychological and psychiatric conditions

Insomnia and mental health symptoms frequently interact in both directions. Anxiety may intensify monitoring and worry, while poor sleep may exacerbate emotional regulation difficulties. Depression may involve insomnia or hypersomnia. Bipolar mood episodes can affect sleep need and timing, and a reduced need for sleep with unusually increased energy requires different clinical attention from ordinary tiredness after a poor night. The Hub has separate articles on anxiety and sleep, depression and sleep, and bipolar disorder and sleep so condition-specific evaluation is not compressed into this insomnia overview.

Who Is More Likely to Develop Insomnia?

Risk varies across the lifespan and with stress exposure, persistent medical or mental health conditions, work schedules, medications, and the individual's sleep opportunity. Adults with caregiving responsibilities, rotating shifts, chronic pain, or repeated schedule disruption may face multiple overlapping risks. Prevalence estimates vary substantially because studies use different definitions of insomnia symptoms and insomnia disorder.

Sex- and age-related patterns can differ across samples, but group-level differences do not determine an individual's diagnosis or treatment. Older adults may encounter more fragmented sleep, chronic conditions, or interacting medications; the practical response is to identify treatable disorders and evaluate safety, especially fall and sedation risk. Pregnancy and the postpartum period bring specific medical and sleep-opportunity considerations; any medication discussion should be individualized with an appropriate clinician.

How Is Insomnia Diagnosed?

Clinical diagnosis begins with a careful conversation about sleep, the daytime effects, and the person's broader health. The NHLBI clinical evaluation guidance explains that clinicians consider symptoms, health history, examination when relevant, and sleep records; tests may be chosen when another disorder is suspected. There is no blood test, wearable score, or single questionnaire result that independently establishes chronic insomnia disorder.

Questions a clinician may ask

• What happens when you try to fall asleep, when you wake during the night, and when you get up?

• How often does the difficulty occur, and for how many weeks or months has it been happening?

• How much time is available for sleep, and what are the usual bed and wake times on workdays and days off?

• How does sleep difficulty affect energy, concentration, mood, safety, relationships, and daily functioning?

• Is there loud snoring, gasping, unpleasant leg sensations, pain, night sweats, abnormal nighttime behavior, or unplanned daytime sleep?

• What medications, caffeine, alcohol, nicotine, supplements, and other substances are involved?

• What happened when symptoms started, and what strategies or treatments have been tried?

Sleep diary

A sleep diary kept for one or two weeks can clarify bedtime, estimated time to fall asleep, awakenings, rise time, naps, schedule variation, and the perceived quality of sleep. The diary is particularly useful because one vivid night can dominate a person's recollection. It can support treatment planning and track trends over time, while remaining a subjective record with its own uncertainty.

An individual entry is rarely decisive. Clinicians interpret diary patterns together with the patient's history, available sleep opportunity, and potential comorbid disorders. Some CBT-I programs use diaries to guide behavioral components, but restricted sleep schedules should be implemented with professional oversight when medical, psychiatric, safety, or occupational risks are present.

Screening questionnaires

The Insomnia Severity Index (ISI) and other validated self-report tools help quantify perceived symptoms and their impact and may monitor change during treatment. Screening scores have different operating characteristics in different settings and populations; they do not replace a clinical diagnosis. The foundational ISI validation research supports this distinction between useful symptom measurement and an independently confirmed disorder.

Actigraphy, polysomnography, and home sleep apnea testing

For uncomplicated chronic insomnia, clinicians usually do not need an overnight laboratory sleep study to establish the diagnosis. Polysomnography becomes relevant when symptoms suggest another sleep disorder, when sleep-related behaviors raise safety questions, or when a specialist needs additional objective information. Actigraphy may help evaluate sleep timing and circadian patterns in selected cases, but it estimates sleep and wake from motion rather than directly measuring every aspect of sleep.

Loud habitual snoring, witnessed breathing pauses, gasping, or high clinical suspicion for obstructive sleep apnea call for separate evaluation. The AASM diagnostic testing guideline for adult sleep apnea specifies when in-laboratory polysomnography is preferred over home testing and explains why a negative or inconclusive home test may require follow-up. Severe insomnia may also affect the suitability of home sleep apnea testing.

Could Something Else Be Causing the Sleep Problem?

Obstructive sleep apnea

Sleep apnea involves repeated interruptions to breathing during sleep. A person may describe frequent awakenings, nonrestorative sleep, and fatigue, symptoms that overlap with insomnia. Snoring and breathing pauses raise suspicion but do not determine the diagnosis. Some patients have both sleep apnea and insomnia, in which case identifying both conditions improves care planning.

Delayed or advanced sleep-wake phase

A delayed sleep-wake phase presents as sleep timing persistently later than desired, with potentially normal sleep when the person follows their preferred schedule. An advanced phase involves unusually early sleep and waking relative to social obligations. Chronic insomnia focuses on difficulty sleeping despite a suitable opportunity at the intended time; timing disorders require assessment of circadian alignment and stable patterns over multiple days.

Restless legs syndrome and limb movements

Restless legs syndrome often causes an urge to move the legs accompanied by uncomfortable sensations that are worse during rest and in the evening and improve temporarily with movement. That pattern differs from ordinary sleep-onset worry. Periodic limb movements may fragment sleep but require separate interpretation and do not automatically explain every insomnia complaint.

Narcolepsy and other hypersomnolence disorders

The dominant complaint in central disorders of hypersomnolence is excessive daytime sleepiness, sometimes with unintended sleep episodes or additional characteristic symptoms. Some patients also experience disrupted nighttime sleep. Marked irresistible sleepiness deserves assessment beyond an insomnia questionnaire, particularly where driving or hazardous activities are involved.

Parasomnias, seizures, and nighttime events

Sleepwalking, dream-enactment behavior, unusual movements, or episodes that could be seizures merit clinical evaluation according to their pattern and safety implications. Violent dream enactment and potential injury are particularly important to assess. These concerns belong to a different diagnostic pathway from insomnia alone.

Mood episodes and other mental health conditions

Reduced need for sleep accompanied by persistently increased energy, unusual agitation or euphoria, impulsive behavior, or other marked changes in mood and functioning warrants prompt professional assessment. Sleep difficulty with severe distress, suicidal thoughts, or a rapidly deteriorating mental state calls for urgent care. The clinical question may involve a mood episode, another mental health condition, and an overlapping sleep complaint.

What Keeps Insomnia Going After the Original Trigger Has Passed?

A period of disrupted sleep can change expectations and daily behavior. Someone might spend much longer in bed to try to recover, remain in bed awake for extended periods, nap at inconsistent times, or check the clock repeatedly. These responses are understandable and can sometimes reduce the distinction between being awake and being asleep, reinforcing an alert association with the bedroom.

The person may also begin predicting failure before bedtime: “I must sleep now or tomorrow will be impossible.” Attention turns toward bodily signals, every awakening becomes an event to analyze, and bedtime can become a performance task. CBT-I addresses these patterns through a structured combination of behavioral adjustments and cognitive techniques. Research supports the treatment as a whole; a single cognitive account cannot explain every case.

Insomnia frequently unfolds as a feedback process. Fragmented or insufficient sleep can make the following day harder; worry about that day can then intensify the next evening. Understanding this cycle helps identify changeable maintenance factors while still taking physical illness, circadian issues, and environmental conditions seriously.

What Is the Best Treatment for Chronic Insomnia?

The strongest first-line evidence for adults with chronic insomnia disorder supports multicomponent CBT-I. The 2021 AASM clinical practice guideline gives CBT-I a strong recommendation. The American College of Physicians guideline likewise recommends it as initial treatment. The 2025 VA/DoD guideline addresses chronic insomnia alongside possible sleep apnea and provides contemporary clinical decision guidance.

Treatment is most effective when matched to the person's diagnosis, current health, practical situation, and safety profile. A sleep clinician, qualified behavioral sleep medicine provider, psychologist trained in CBT-I, or appropriately supported digital program may provide treatment. For someone whose sleep complaint stems mainly from an untreated circadian disorder or significant breathing disturbance, disorder-specific assessment remains essential.

Cognitive behavioral therapy for insomnia (CBT-I)

CBT-I is a structured intervention that works on the behaviors and thoughts that maintain chronic insomnia. It commonly includes education about the sleep system, stimulus control, a carefully supervised sleep scheduling or sleep restriction/compression component when appropriate, cognitive techniques, and supportive sleep-health practices. The selection and intensity of components vary across providers and patient needs.

Randomized trials and systematic reviews support meaningful improvements in patient-reported insomnia symptoms, time spent awake at night, and perceived sleep quality for many adults. Benefits can persist after active treatment ends. The AASM's systematic review and meta-analysis explains the evidence underlying the guideline, as well as its limitations. Not every patient responds in the same way, and outcomes depend on adherence, suitability, access, and accompanying conditions.

Stimulus control: rebuilding the association between bed and sleep

Stimulus control seeks to reduce extended wakeful periods in bed and strengthen the association between the sleep setting and sleep. A clinician may help someone build a consistent waking pattern, choose bedtime in relation to genuine sleepiness, and respond flexibly to prolonged wakefulness rather than struggle for hours. Its purpose is to change learned patterns, not to turn sleep into another rigid performance test.

Plans must account for disability, mobility constraints, caregiving, medications, and night-shift obligations. General descriptions online cannot replace a personalized clinical protocol where nighttime movement, falls, or safety issues are relevant.

Sleep scheduling and sleep restriction therapy

One CBT-I component temporarily adjusts the time allotted for sleep in relation to a person's actual sleep pattern, with subsequent changes guided by response. The approach can improve sleep consolidation, but it can also increase sleepiness at first. It requires individualized screening for risks such as bipolar mood instability, seizure vulnerability, occupational driving, fall risk, and significant daytime impairment.

People should not independently impose severe sleep curtailment or use an online calculator to select a restrictive schedule. An appropriately qualified provider can decide whether a gentler sleep compression approach, modifications, or an alternative component is more suitable. Safety and functioning throughout the day are essential treatment outcomes.

Cognitive techniques and reducing sleep-related anxiety

CBT-I can address catastrophic predictions about a poor night, clock monitoring, unhelpful rules about sleep, and the belief that falling asleep requires forceful effort. Some techniques focus on examining predictions against experience and reducing arousal; others support a more flexible response to normal night-to-night variation. The goal is to restore more workable patterns of sleep and daytime functioning.

Relaxation and related approaches

Relaxation methods, including approaches to muscle tension and physiological arousal, may help selected patients. AASM guidance conditionally supports some single-component behavioral interventions, while multicomponent CBT-I carries the strongest overall recommendation. Relaxation alone is not necessarily sufficient for chronic insomnia disorder, especially where conditioned waking, incompatible time in bed, and persistent insomnia-related fears interact.

How long does CBT-I take?

Many structured CBT-I programs are delivered over several sessions, often across roughly four to eight weeks, although formats and duration vary. Some people experience early improvement and others progress more gradually. A short-lived increase in perceived tiredness can occur during certain behavioral components; this is a reason for monitoring and tailoring rather than rigidly pushing through adverse effects. Follow-up helps consolidate gains and identify any ongoing medical or circadian contributors.

Can Digital CBT-I Work?

Digital CBT-I programs can deliver structured educational, cognitive, and behavioral treatment modules remotely, sometimes with clinician support. A 2025 systematic review and meta-analysis of automated digital CBT-I reported improvements in insomnia outcomes across randomized trials, while also identifying variation in delivery, comparison conditions, and study quality. Evidence for a studied CBT-I program cannot be generalized to every commercial sleep app.

Good digital programs describe their clinical framework, suitability criteria, safety screening, progress monitoring, and what to do when symptoms worsen. Someone with possible sleep apnea, complex psychiatric or neurological issues, significant sleepiness, pregnancy-related concerns, or occupational safety needs may require clinical evaluation and a more supervised treatment plan.

Digital sleep diaries and guided CBT-I modules are interventions with defined content. General-purpose chatbots, passive sleep trackers, calming sounds, and generic sleep tips are different products with different evidence. Popularity, personalization features, or an attractive sleep score do not establish effectiveness for treating chronic insomnia disorder.

Do Sleep Hygiene Changes Treat Insomnia?

Sleep hygiene includes practical sleep-supporting conditions such as a suitable environment, consistent scheduling where feasible, attention to substances, and enough opportunity for sleep. These measures may reduce avoidable barriers to rest. Yet the AASM specifically recommends against sleep hygiene as a standalone therapy for adult chronic insomnia disorder. People can practice many healthy habits and still have persistent clinical insomnia.

A person with insomnia may benefit from reviewing the role of caffeine, alcohol, nicotine, heavy meals close to bedtime, irregular schedules, and excessive nighttime light. The best adjustments depend on the person's schedule and health. For example, someone with late shifts has different constraints from someone following a conventional daytime routine. Supportive sleep habits work best within an appropriate diagnostic and treatment plan.

Does avoiding screens cure insomnia?

Evening device use can delay bedtime or increase alertness through engaging content, light exposure, or worry-driven checking. Reducing these factors may be useful, but turning off screens cannot be considered a stand-alone clinical treatment for chronic insomnia. The distinct behavioral mechanisms are examined in the Hub's screen time and sleep article.

Should everyone stop caffeine at the same time?

Caffeine sensitivity, quantity, timing, interacting medications, and individual sleep timing vary. Reviewing afternoon or evening intake can help clarify a contributor, especially when stimulant exposure coincides with symptoms. There is no single cutoff that proves a diagnosis or cures insomnia. See the Hub's separate coffee and sleep evidence guide for the caffeine-specific questions.

What Medications Are Used for Insomnia?

Prescription medication can have a role for selected patients, particularly when insomnia symptoms are severe or other treatment is unavailable, inappropriate, or insufficient. Options differ in mechanisms, expected benefits, dosing context, contraindications, interactions, next-day sedation, and risks. A treatment decision must consider the person's age, other medicines, breathing disorders, substance-use history, mental health, and daily activities.

The AASM's 2017 pharmacologic clinical guideline provides medication-specific recommendations for chronic insomnia in adults. These recommendations are generally conditional, reflecting limited evidence and a need for individualized judgment. The medications discussed in that guideline should not be treated as universally interchangeable or suitable for every type of sleep complaint.

What do the 2026 combination-treatment recommendations say?

In April 2026, the AASM published a clinical practice guideline on combining CBT-I with insomnia medication. It conditionally suggests CBT-I plus medication rather than medication alone, while conditionally suggesting against routine combination treatment instead of CBT-I alone. Both recommendations rest on low-certainty evidence. The guideline notes that an individual prioritizing increased sleep time early in treatment may reasonably select combination treatment with a clinician.

These recommendations preserve CBT-I as the central evidence-based intervention. Whether to add medication, for how long, and how to monitor effects is a shared clinical decision informed by response and risks. Medication should not replace evaluation for sleep apnea or other relevant conditions.

Why medication safety matters

Certain sedative-hypnotic medications can cause next-day impairment, falls, and unusual sleep-related behaviors. The U.S. Food and Drug Administration has required boxed warnings for complex sleep behaviors with certain Z-drugs, including sleepwalking or performing activities while not fully awake, with reports of serious injury. A person experiencing dangerous behaviors, severe adverse effects, or unexpected impairment needs prompt medical advice.

Some medicines are associated with tolerance, dependence, withdrawal symptoms, or rebound insomnia; risk varies by medication and patient. Abruptly stopping prescribed sleeping medication can be unsafe. People taking these drugs should speak with the prescribing clinician about ongoing need and any planned changes, and avoid driving or hazardous activities when impaired.

What about melatonin, antihistamines, and supplements?

Melatonin has a physiological role in signaling biological night, and timing is clinically relevant for certain circadian rhythm conditions. Evidence does not make melatonin a first-line replacement for CBT-I in chronic insomnia disorder. Over-the-counter sedating antihistamines may cause anticholinergic adverse effects and residual sedation; these concerns are especially important in older adults. Herbal preparations and supplements vary in quality, interactions, and evidence; natural origin is not a reliable safety indicator.

Any recommendation involving prescription drugs, over-the-counter sleep aids, or supplements should reflect the person's actual diagnosis, concurrent medication, pregnancy status where relevant, and clinical risks. It is unhelpful to treat every product marketed for sleep as an equivalent insomnia therapy.

How Are Insomnia and Mental Health Connected?

Sleep disturbance can accompany changes in mood, anxiety, trauma-related arousal, obsessive-compulsive symptoms, and chronic stress. Insomnia can also persist as a clinically important target in its own right. Treating both the relevant mental health condition and the insomnia mechanism may be appropriate, depending on the situation.

Readers whose primary question concerns a specific diagnosis can explore the Hub's evidence-based articles on PTSD-related sleep problems, anxiety and sleep, depression and sleep, and OCD and sleep. This separation protects clear clinical pathways: a guide to insomnia treatment must not substitute for a focused assessment of psychiatric symptoms.

Insomnia in Older Adults, Children, and Special Circumstances

Older adults

Changes in circadian timing, nighttime awakenings, medical conditions, and medication use may complicate sleep complaints in later life. A common mistake is to dismiss prolonged distress as inevitable aging, or to prescribe sedating medications without evaluating fall risk, breathing disorders, cognition, and daytime function. CBT-I can be adapted to older adults, including practical accommodations for mobility and medical comorbidity.

Children and adolescents

Sleep difficulties in children require age-appropriate consideration of sleep need, family routines, developmental context, school schedules, emotional factors, and medical symptoms. Adult chronic-insomnia criteria and treatment protocols should not be transplanted unchanged. Pediatric assessment and behavioral interventions are tailored to the child's age and family setting.

Pregnancy and postpartum

Pregnancy and the postpartum period may involve frequent awakenings, discomfort, hormonal change, infant caregiving, mood symptoms, and constrained sleep opportunity. These circumstances affect diagnosis and treatment selection. Individualized nonpharmacologic care and appropriate obstetric or medical guidance are particularly important for medication decisions.

Shift workers and people with irregular schedules

Workers on nights, rotating shifts, or unpredictable schedules may experience insufficient sleep opportunity and circadian misalignment. When insomnia complaints occur mainly in relation to work timing, clinicians consider a possible circadian rhythm sleep-wake disorder or a combination of conditions. Workplace safety, driving, light exposure, and recovery time are critical parts of the assessment.

What Can You Do While Arranging Professional Care?

Begin by observing the pattern rather than judging a single night. For a week or two, record bed and wake times, major awakenings, naps, alcohol and caffeine timing, medication changes, symptoms such as snoring or leg discomfort, and the next day's functioning. If monitoring increases anxiety, a simpler record or clinician-guided diary may be more useful than repeated self-measurement.

Protect a realistic opportunity to sleep within the constraints of daily life. Identify obvious disruptors such as nighttime noise, overheating, or very late stimulant intake; address them without turning every night into an elaborate ritual. Pay attention to driving and work safety whenever substantial sleepiness or impaired alertness is present. Keep a list of questions and relevant medicines for an appointment.

When chronic insomnia is likely, ask about access to qualified CBT-I rather than relying exclusively on sleep hygiene instructions. When severe snoring, gasping, unusual nighttime behaviors, uncomfortable leg sensations, or other distinctive symptoms are present, tell the clinician so that other sleep disorders are considered. This path joins practical action with diagnostic accuracy.

When Should You Seek Medical Help?

Arrange a clinical evaluation when insomnia persists, repeatedly affects daytime functioning, or leads to substantial distress. Evaluation is particularly important when symptoms last three months or longer, when a sleep disorder is suspected, when medication use is changing, or when a patient has relevant medical or psychiatric comorbidities. A primary care professional can assess the presentation and determine whether referral to a sleep specialist or CBT-I provider is appropriate.

Seek prompt medical attention for concerning breathing episodes, dangerous sleep behaviors, abrupt and severe changes in mental state, or inability to stay awake during important activities. Never drive when dangerously sleepy. If someone is experiencing suicidal thoughts, imminent self-harm risk, or a psychiatric emergency, urgent local emergency or crisis services are appropriate. Markedly decreased need for sleep with unusually high energy or behavioral changes also warrants prompt mental health assessment.

Common Misconceptions About Insomnia

“Every poor night means I have insomnia disorder.”

People can experience temporary sleeplessness in response to life events, a late-night schedule, or illness. A disorder-level assessment considers persistence, frequency, sleep opportunity, daytime consequences, and the wider clinical picture.

“If I sleep enough hours, I cannot have insomnia.”

Sleep continuity, timing, and daytime consequences matter alongside total duration. Someone may remain in bed for many hours and still have distressing difficulty sleeping. Conversely, an individual who sleeps fewer hours but functions well does not automatically have insomnia.

“A sleep tracker knows exactly how well I slept.”

Consumer devices estimate aspects of sleep from indirect signals and their performance varies across devices and conditions. A displayed number is not a diagnosis, and intensive score-checking can sometimes increase concern about sleep. Clinicians prioritize symptoms and functioning and use formal testing when indicated.

“Good sleep hygiene is all the treatment I need.”

Practical sleep-health habits can support care, but multicomponent CBT-I is the guideline-recommended first-line treatment for adult chronic insomnia. An unsuccessful attempt to follow generic advice does not mean treatment has failed; it may mean the person has not yet received a targeted, evidence-based intervention.

“Insomnia medication is always the fastest or best long-term solution.”

Medication decisions depend on the clinical context and risk-benefit balance. Research supports CBT-I as initial treatment for most adults with chronic insomnia, with medication sometimes considered through shared decision-making. The 2026 AASM combination guideline makes the distinction especially clear: adding a drug is not routinely preferred to CBT-I alone.

Frequently Asked Questions About Insomnia

Can insomnia go away on its own?

An episode triggered by an illness, travel, or a stressful event may improve when circumstances settle. Persistent symptoms, learned sleep-related worry, and repeated disruption can prolong the problem. When sleep difficulty becomes frequent and clinically impairing, evidence-based treatment improves the chances of sustained change.

How many hours of sleep counts as insomnia?

There is no single hourly cutoff. Clinical insomnia concerns difficulty initiating or maintaining sleep despite an adequate opportunity, plus relevant daytime consequences and a pattern of duration and frequency. Recommended sleep duration and individual sleep need are related topics but do not replace diagnostic criteria.

Is insomnia the same as sleep deprivation?

Sleep deprivation means receiving less sleep than needed, often because the opportunity to sleep is limited. Insomnia concerns difficulty sleeping despite opportunity. A person can have either condition or both; distinguishing them determines which problem needs attention first.

Can anxiety cause insomnia?

Worry and heightened arousal may precipitate or maintain insomnia. Anxiety disorders and insomnia often coexist, and their symptoms may reinforce each other. A clinical evaluation clarifies whether insomnia-focused treatment, anxiety-focused care, or both are indicated.

Can depression cause insomnia?

Depression may involve difficulty sleeping, early waking, or sleeping more than usual. Insomnia can also occur independently or remain after other symptoms improve. Persistent low mood, loss of interest, and other concerning signs warrant assessment without assuming sleep problems establish depression.

Is CBT-I effective without sleeping pills?

Yes. Multicomponent CBT-I has a strong AASM recommendation and is a first-line intervention for adult chronic insomnia. The 2026 combination-treatment guideline does not find sufficient grounds to prefer routine addition of medication over CBT-I alone. A clinician can tailor treatment where comorbidity, access, and individual priorities complicate care.

Is CBT-I the same as traditional talk therapy?

CBT-I is a specialized, structured treatment for insomnia. It uses sleep-specific behavioral and cognitive approaches and often requires tracking sleep patterns across sessions. General supportive counseling can help broader distress, but its evidence and techniques are not automatically equivalent to a full CBT-I protocol.

Can I diagnose insomnia from an online screening test?

No. Screening questionnaires can quantify symptom severity and identify people who may benefit from assessment. Diagnostic decisions require the pattern, adequate sleep opportunity, daytime consequences, and consideration of other causes. Sleep apnea and other disorders can coexist with a high insomnia score.

Do I need a sleep study?

Usually not for straightforward insomnia. A clinician may request testing if breathing disturbances, unusual nighttime behaviors, abnormal daytime sleepiness, or other findings suggest a different condition. Tests are chosen for the suspected disorder, not simply because sleep has been difficult.

Does melatonin cure chronic insomnia?

Melatonin is not a universal treatment for chronic insomnia disorder. Some circadian conditions involve carefully timed melatonin as part of a distinct care plan. Timing, interactions, age, and other clinical features determine whether it is appropriate.

What if insomnia treatment does not work?

Reassessment can identify an overlooked sleep or medical disorder, a mismatched treatment component, insufficient delivery of CBT-I, medication effects, schedule conflicts, or an unaddressed mental health condition. Treatment may need adjustment, a different delivery format, or specialist referral. Persistence of symptoms is a reason for a more informative clinical review.

The Clinical Takeaway

Insomnia deserves assessment when repeated sleep difficulty occurs despite adequate opportunity and affects life during the day. Understanding sleep timing, physical symptoms, psychological maintenance factors, and other sleep disorders makes the diagnosis more accurate. For most adults with chronic insomnia disorder, multicomponent CBT-I is the evidence-based starting point, supported by individualized medical evaluation and careful consideration of medication risks. Progress is best judged by the pattern of sleep, distress, functioning, and safety over time rather than by perfection on any particular night.

Related Articles

• Anxiety and Sleep: Insomnia, Hyperarousal, and the Anxiety-Sleep Cycle

• PTSD and Sleep Problems: Insomnia, Hyperarousal, and Treatment

• Depression and Sleep: Insomnia, Oversleeping, and Treatment

• Bipolar Disorder and Sleep: Mood Episodes, Circadian Rhythms, and Prevention

• OCD and Sleep: Insomnia, Delayed Sleep, Nighttime Rituals, and Symptom Severity

• Screen Time and Sleep: How Evening Device Use Affects Bedtime and Rest

• Coffee and Sleep: How Caffeine Timing, Dose, and Sensitivity Affect Rest

Digital CBT-I: Online Treatment for Chronic Insomnia — online program evidence, safety, access, and privacy.

Sleep Psychology: How Sleep Works and Why It Matters

Insomnia Assessment: Sleep Diaries, Clinical Questions, and Tests

Cognitive Behavioral Therapy for Insomnia (CBT-I): How It Works

Trouble Falling Asleep: Causes and What Helps

References

American Academy of Sleep Medicine. (2023). International Classification of Sleep Disorders, Third Edition, Text Revision (ICSD-3-TR). Official classification information.

Buysse, D. J., Arnedt, J. T., Buenaver, L., et al. (2026). Combination treatment for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. https://doi.org/10.1007/s44470-025-00038-8.

Edinger, J. D., Arnedt, J. T., Bertisch, S. M., et al. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255–262. https://doi.org/10.5664/jcsm.8986.

Edinger, J. D., Arnedt, J. T., Bertisch, S. M., et al. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.8988.

Hwang, J. W., Lee, G. E., Woo, J. H., Kim, S. M., & Kwon, J. Y. (2025). Systematic review and meta-analysis on fully automated digital cognitive behavioral therapy for insomnia. npj Digital Medicine, 8, Article 157. Original research article.

Kapur, V. K., Auckley, D. H., Chowdhuri, S., et al. (2017). Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea. Journal of Clinical Sleep Medicine, 13(3), 479–504. https://doi.org/10.5664/jcsm.6506.

Morin, C. M., Belleville, G., Bélanger, L., & Ivers, H. (2011). The Insomnia Severity Index: Psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep, 34(5), 601–608. PubMed record.

National Heart, Lung, and Blood Institute. (n.d.). Insomnia: Causes. National Institutes of Health. Official guidance.

National Heart, Lung, and Blood Institute. (n.d.). Insomnia: Diagnosis. National Institutes of Health. Official guidance.

National Heart, Lung, and Blood Institute. (n.d.). Insomnia: Symptoms. National Institutes of Health. Official guidance.

National Heart, Lung, and Blood Institute. (n.d.). Insomnia: Treatment. National Institutes of Health. Official guidance.

Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125–133. https://doi.org/10.7326/M15-2175.

Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13(2), 307–349. https://doi.org/10.5664/jcsm.6470.

Tang, N. K. Y., Saconi, B., Jansson-Fröjmark, M., Ong, J. C., & Carney, C. E. (2023). Cognitive factors and processes in models of insomnia: A systematic review. Journal of Sleep Research, 32(6), e13923. https://doi.org/10.1111/jsr.13923.

U.S. Department of Veterans Affairs & U.S. Department of Defense. (2025). VA/DoD Clinical Practice Guideline for the Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea. Official guideline.

U.S. Food and Drug Administration. (2019). Certain prescription insomnia medicines: New boxed warning due to risk of serious injuries caused by complex sleep behaviors. FDA safety communication.